Study of TP-04 in Participants With Papulopustular Rosacea

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This study is being done to evaluate the safety, tolerability, and efficacy of the study drug, TP-04, in participants with papulopustular rosacea (PPR).
Epistemonikos ID: 76183fdee02adc43784e9cc71c4a743283c465ea
First added on: Feb 19, 2024